Sigi Kay

Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy—A Single-Center Prospective Cohort Study

Ron Ram, David Hagin, Nino Kikozashvilli et al. · Transplantation and Cellular Therapy · 2021 · 159 citations · Full text

The CXCR4 antagonist AMD3100 impairs survival of human AML cells and induces their differentiation

Sigal Tavor, Manny Eisenbach, Jasmine Jacob‐Hirsch et al. · Leukemia · 2008 · 105 citations

Inflammation, Cytokine, Cell Regulation +8

Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia

Mika Shapiro, Yair Herishanu, Ben‐Zion Katz et al. · Haematologica · 2017 · 95 citations · Full text

Toxicity and efficacy of chimeric antigen receptor T-cell therapy in patients with diffuse large B-cell lymphoma above the age of 70 years compared to younger patients – a matched control multicenter cohort study

Ron Ram, Sigal Grisariu, Liat Shargian et al. · Haematologica · 2021 · 62 citations · Full text

Clinical Immunology, Elderly Patients, Immunodeficiencies +21

Endurance Exercise Diverts the Balance between Th17 Cells and Regulatory T Cells

Chava Perry, Marjorie Pick, Nir Bdolach et al. · PLoS ONE · 2013 · 50 citations · Full text

Lung Inflammation, T-regulatory Cell, Immunology +29